ITF-2357 (Givinostat) Hydrochloride Monohydrate Mechanism of Action: HDAC Inhibition in Skeletal Muscle Cell Research

ITF-2357 (Givinostat) Hydrochloride Monohydrate MOA:Targeting HDAC/Follistatin Pathway for Duchenne Muscular Dystrophy

🎯 check ITF-2357 (Givinostat) Hydrochloride Monohydrate product page

ITF-2357 (Givinostat) Hydrochloride Monohydrate is a potent pan-HDAC inhibitor. It affects TGF-β1 and NF-κB signaling by inducing histone hyperacetylation and modulating gene expression, effectively inhibiting tumor proliferation, inflammation, and fibrosis while promoting apoptosis.

Primary Applications and Mechanism of Action